GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,761 | +33.3% | 5,605 | 0.0% | 0.00% | – |
| Q2 2023 | $8,071 | -31.4% | 5,605 | 0.0% | 0.00% | – |
| Q1 2023 | $11,770 | +75.2% | 5,605 | -5.7% | 0.00% | – |
| Q4 2022 | $6,717 | -32.8% | 5,945 | -0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 5,947 | -23.7% | 0.00% | – |
| Q2 2022 | $10,000 | -33.3% | 7,797 | -18.8% | 0.00% | – |
| Q1 2022 | $15,000 | +7.1% | 9,597 | +46.5% | 0.00% | – |
| Q4 2021 | $14,000 | -33.3% | 6,553 | +18.8% | 0.00% | – |
| Q3 2021 | $21,000 | -47.5% | 5,517 | -54.8% | 0.00% | – |
| Q2 2021 | $40,000 | -61.2% | 12,217 | -74.3% | 0.00% | – |
| Q1 2021 | $103,000 | +329.2% | 47,623 | +341.3% | 0.00% | – |
| Q4 2020 | $24,000 | +20.0% | 10,791 | +43.4% | 0.00% | – |
| Q3 2020 | $20,000 | -39.4% | 7,526 | -30.9% | 0.00% | – |
| Q2 2020 | $33,000 | +266.7% | 10,895 | +145.8% | 0.00% | – |
| Q1 2020 | $9,000 | -66.7% | 4,433 | -54.5% | 0.00% | – |
| Q4 2019 | $27,000 | -32.5% | 9,742 | -12.0% | 0.00% | – |
| Q3 2019 | $40,000 | -9.1% | 11,076 | +2.5% | 0.00% | – |
| Q2 2019 | $44,000 | -60.7% | 10,810 | -50.9% | 0.00% | – |
| Q1 2019 | $112,000 | +646.7% | 22,029 | +400.7% | 0.00% | – |
| Q4 2018 | $15,000 | -60.5% | 4,400 | -31.0% | 0.00% | – |
| Q3 2018 | $38,000 | +100.0% | 6,375 | +112.5% | 0.00% | – |
| Q2 2018 | $19,000 | -51.3% | 3,000 | -63.7% | 0.00% | – |
| Q1 2018 | $39,000 | +62.5% | 8,260 | +13.9% | 0.00% | – |
| Q4 2017 | $24,000 | +50.0% | 7,250 | -4.6% | 0.00% | – |
| Q3 2017 | $16,000 | +14.3% | 7,603 | +32.2% | 0.00% | – |
| Q2 2017 | $14,000 | +7.7% | 5,750 | -1.3% | 0.00% | – |
| Q1 2017 | $13,000 | +44.4% | 5,828 | -37.4% | 0.00% | – |
| Q4 2016 | $9,000 | -10.0% | 9,308 | -0.0% | 0.00% | – |
| Q3 2016 | $10,000 | -33.3% | 9,310 | -4.6% | 0.00% | – |
| Q2 2016 | $15,000 | 0.0% | 9,759 | -4.1% | 0.00% | – |
| Q1 2016 | $15,000 | -11.8% | 10,177 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | -56.4% | 10,177 | -39.5% | 0.00% | – |
| Q3 2015 | $39,000 | -18.8% | 16,817 | -4.5% | 0.00% | – |
| Q2 2015 | $48,000 | -20.0% | 17,615 | -0.5% | 0.00% | – |
| Q1 2015 | $60,000 | +62.2% | 17,696 | +65.1% | 0.00% | – |
| Q4 2014 | $37,000 | -56.0% | 10,717 | -35.5% | 0.00% | – |
| Q3 2014 | $84,000 | +12.0% | 16,621 | +209.7% | 0.00% | – |
| Q2 2014 | $75,000 | -30.6% | 5,367 | -24.1% | 0.00% | – |
| Q1 2014 | $108,000 | +575.0% | 7,067 | +245.6% | 0.00% | – |
| Q4 2013 | $16,000 | – | 2,045 | +4547.7% | 0.00% | – |
| Q2 2013 | $0 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |